Stocks Health care BLSM
Health careBlossomHill Therapeutics, Inc. (BLSM)
At June 30, 2026 it held $95.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 18, 2026.
What BlossomHill Therapeutics, Inc. does
BlossomHill Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations).
Latest SEC filings
What BlossomHill Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 18, 2026Quarterly report 10-Q · period to June 30, 2026
- September 18, 2026
- September 15, 2026
- August 18, 2026Activist stake (5% or more) SCHEDULE 13D
- August 17, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 13, 2026Activist stake (5% or more) SCHEDULE 13D
- August 10, 2026
- August 10, 2026
- August 7, 2026
Questions about BLSM
What does BlossomHill Therapeutics, Inc. do?
BlossomHill Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations).
When did BlossomHill Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 18, 2026. It covers the period to June 30, 2026.
Similar companies
Follow BLSM
Get an email when BlossomHill Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BLSM: get an email when it filesWhere the numbers come from
Financial figures are the values BlossomHill Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.